CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,952,385
- in 10 filings, $770K under 10b5-1 plans
Net −$3,952,385. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | EAGLE CRAIG Chief Medical Officer | Exercise or conversion | +3,718 | 36,318 | ||
| 2025-05-15 | EAGLE CRAIG Chief Medical Officer | Shares withheld for taxes | −1,885 | $40.46 | $76K | 34,433 |
| 2025-05-15 | EAGLE CRAIG Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −3,718 | 0 | ||
| 2025-05-15 | Chudova Darya Chief Technology Officer | Exercise or conversion | +8,705 | 83,210 | ||
| 2025-05-15 | Chudova Darya Chief Technology Officer | Shares withheld for taxes | −4,412 | $40.46 | $179K | 78,798 |
| 2025-05-15 | Chudova Darya Chief Technology Officer | Exercise or conversion · Restricted Stock Units | −8,705 | 17,411 | ||
| 2025-05-04 | Joyce Meghan V. Director | Exercise or conversion | +66 | 7,846 | ||
| 2025-05-04 | Joyce Meghan V. Director | Exercise or conversion · Restricted Stock Units | −66 | 200 | ||
| 2025-05-02 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −13,932 | $50.47 | $703K | 2,188,740 |
| 2025-05-01 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −18,069 | $47.67 | $861K | 2,291,387 |
| 2025-05-01 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −38,477 | $48.71 | $1.9M | 2,252,910 |
| 2025-05-01 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −44,691 | $49.53 | $2.2M | 2,208,219 |
| 2025-05-01 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −3,445 | $50.91 | $175K | 2,204,774 |
| 2025-05-01 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −1,748 | $51.56 | $90K | 2,203,026 |
| 2025-05-01 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −354 | $52.57 | $19K | 2,202,672 |
| 2025-04-30 | Krognes Steve E. Director | Exercise or conversion | +155 | 10,837 | ||
| 2025-04-30 | Krognes Steve E. Director | Exercise or conversion · Restricted Stock Units | −155 | 2,160 | ||
| 2025-04-17 | Tariq Musa Director | Sale 10b5-1 | −116 | $44.79 | $5K | 3,345 |
| 2025-04-15 | Tariq Musa Director | Exercise or conversion | +250 | 3,461 | ||
| 2025-04-15 | Tariq Musa Director | Exercise or conversion · Restricted Stock Units | −250 | 5,747 |
Page 50 of 57 · 1,133 trades